About Tinatin

Dr. Tinatin Kuchuloria holds her M.D. degree from the Tbilisi State Medical University, Georgia (2002) and a Ph.D. degree in Public Health from the Tbilisi State University, Georgia (2016). Currently she is a candidate for M.Sc. degree in Public Health from the London School of Hygiene and Tropical Medicine, United Kingdom. Dr. Kuchuloria was working as a physician researcher and a clinical program coordinator at the United States Army Medical Research Institute clinical research unit in Georgia (2007-2012) and US Army Medical Research Directorate - Georgia (2012-2016).  The list of projects that she led as Principle Investigator includes: acute febrile illness surveillance in the country of Georgia, active surveillance of tularemia in Georgia, and the assessment of the long-term immunologic response to anthrax infection in Georgia. As a clinical co-investigator, she participated in several studies on infectious diseases in the countries of Georgia and Armenia. As a clinical program coordinator, she participated in the planning and implementation of the water-borne tularemia outbreak investigation and follow-up study, and the clinicians training program on the clinical recognition of the especially dangerous pathogens.

Since fall 2016 Dr. Kuchuloria has been working as a scientific coordinator at the CDC Foundation for US Centers for Disease Control and Prevention on the Georgia National Hepatitis C Elimination Program.  As part of her current job Dr. Kuchuloria coordinates and oversees activities that relate to the Georgia National Hepatitis C Elimination Program Scientific Committee.

This speaker will be presenting at the following session(s)

  • The critical role of strategic information: HCV elimination in Georgia

    Ballroom 1

    Day: 1 November

    Time: 15:30

    Chairs: Dr. Francisco Averhoff, US Centers for Disease Control and Prevention and Dr. Helen Harris, Public Health England


    • The birth of The HCV elimination in Georgia: the focus on strategic information.
    • Assessing the burden of disease: the planning, conduct and use of a National Seroprevalence Survey.
    • Dr. Amiran Gamkrelidze, National Center for Disease Control and Public Health of Georgia
    • Monitoring the care cascade: developing a robust screening and treatment information system.
    • Dr. Lia Gvinjilia, CDC Foundation
    • The critical role of research in HCV elimination.
    • Dr. Tinatin Kuchuloria, CDC Foundation
    • Modelling the epidemic to guide interventions.
    • Prof. Peter Vickerman, University of Bristol, UK
    • Q & A session.

    Session objectives:

    • Learn the importance of a well conducted population serosurvey to guide development of an evidence-based national strategy/plan.
    • Understand the importance of a robust strategic information system to guide and monitor an elimination program.
    • Learn the key role of partnerships in developing a world class information system.